Sleep Quality Linked to Alzheimer's Disease

According to a new study published by Johns Hopkins Bloomberg School of Public Health, sleep quality may influence the onset and progression of Alzheimer's disease. Lead author, Adam Spira, PhD, and his team of researchers discovered a link between shorter and/or poor sleep quality and higher levels of Amyloid beta build-up in the brain.

“Amyloid beta is a peptide of 36–43 amino acids that is processed from the amyloid precursor protein (APP). While best known as a component of amyloid plaques in association with Alzheimer's disease, as Aβ is the main component of certain deposits found in the brains of patients with Alzheimer's disease, evidence has been found that Aβ is a highly multifunctional peptide with significant non-pathological activity.” 

Researchers observed self-reported sleep habits and β-Amyloid deposits of adults from the neuro-imaging sub-study of the Baltimore Longitudinal Study of Aging where the average participant age was 76 years. Subjects reported sleep that ranged from more than 7 hours to no more than 5 hours. Using the Pittsburgh compound B tracer and PET scans of the brain to determine the amount of β-Amyloid in the brain, researchers noted that shorter sleep duration and lower sleep quality were both associated with greater amounts of β-Amyloid deposits.

Even though no causal link has been established, if sleep habits do in fact have such an impact, researchers suggest that these findings could potentially slow the progression of Alzheimer’s simply by promoting and maintaining healthy sleep patterns. Furthermore, as this is not the first study to link sleep and Alzheimer’s disease, more research with objective sleep measures could determine whether poor sleep actually contributes to or accelerates Alzheimer's disease.

“Results could have significant public health implications as Alzheimer's disease is the most common cause of dementia, and approximately half of older adults have insomnia symptoms."

Alzheimer's disease is a type of dementia that causes problems with memory, thinking and behaviour. It is most common in people over 65 years of age; however up to 5% of people develop early-onset in their 40s or 50s. The most common early symptom of Alzheimer's is difficulty remembering newly learned information as changes in the part of the brain associated with learning is often the first to be affected. Eventually these individuals will experience symptoms, including disorientation, mood and behaviour changes; more serious confusion about events, time and place; unfounded suspicions about family, friends and professional caregivers; more severe memory loss and behaviour changes; followed by difficulty speaking, swallowing and walking.

Shorter Sleep Duration, Poorer Sleep Quality Linked to Alzheimer ’s Disease
Beta amyloid
Alz.org

 © www.mentalhealthblog.com

Read More

Diabetic Medication Helps Improve Memory

Researchers at the University of Texas Medical Branch at Galveston revealed that an FDA-approved medication called rosiglitazone that is used to treat insulin resistance in diabetics also enhances learning and memory. This discovery could improve cognitive performance for those with Alzheimer’s disease.

By studying genetically engineered mice designed to serve as models for Alzheimer's, “the scientists believe that the drug produced the response by reducing the negative influence of Alzheimer's on the behavior of a key brain-signaling molecule.”

The molecule in question is called extracellular signal-regulated kinase (ERK). In the brains of Alzheimer's patients as well as the mice in the study, this molecule becomes hyperactive, which leads to improper synaptic transmission between neurons thereby interfering with learning and memory.

“Rosiglitazone brings ERK back into line by activating what's known as the peroxisome proliferator-activated receptor gamma (PPARγ) pathway, which interacts with genes that respond to both PPARγ and ERK.”

Basically, the medication helps to restore signals between neurons so that cognitive functions become more normal. This research opens a gateway allowing researchers to test more FDA-approved drugs to try and normalize insulin resistance in Alzheimer's patients while potentially improving their memory at the same time. It could also lead to a greater understanding of the biology behind the cognitive issues in Alzheimer's disease.

Alzheimer's disease (AD) is the most common form of dementia. There is no cure for the disease, which worsens as it progresses, and eventually leads to death.

Symptoms:

• Memory loss that disrupts daily life.
• Challenges in planning or solving problems.
• Difficulty completing familiar tasks at home, at work or at leisure.
• Confusion with time or place.
• Trouble understanding visual images and spatial relationships.
• New problems with words in speaking or writing.
• Misplacing things and losing the ability to retrace steps.
• Decreased or poor judgment.
• Withdrawal from work or social activities.
• Changes in mood and personality.

Prevalence:

• An estimated 5.4 million Americans of all ages have Alzheimer’s disease in 2012. This figure includes 5.2 million people age 65 and older and 200,000 individuals under age 65 who have younger-onset Alzheimer’s.
• One in eight people age 65 and older (13 percent) has Alzheimer’s disease.
• Nearly half of people age 85 and older (45 percent) have Alzheimer’s disease.
• Of those with Alzheimer’s disease…
• an estimated 4 percent are under age 65
• 6 percent are 65 to 74
• 44 percent are 75 to 84
• 46 percent are 85 or older
• Every 68 seconds, someone in America develops Alzheimer’s.
• By mid-century, someone in America will develop the disease every 33 seconds.

Diabetes Drug Improves Memory, Study Suggests
Alzheimer's disease
Facts and Figures facts and figures

© www.mentalhealthblog.com

Read More

Early Emotional Neglect May Predict Strokes

New research conducted by the Rush Alzheimer's Disease Center at Rush University Medical Center suggests that emotionally neglected children are at risk of stroke as adults. 

"Studies have shown that children who were neglected emotionally in childhood are at an increased risk of a slew of psychiatric disorders. However, our study is one of few that looked at an association between emotional neglect and stroke," said study author Robert S. Wilson, PhD, a neuropsychologist at Rush.

Researchers’ selected 1,040 participants aged 55+ without dementia from the Memory and Aging Project were surveyed on physical and emotional abuse before the age of 18. Participants were questioned on such areas as how much love they felt from their parents or caregivers as children, whether they felt afraid or intimidated by their caregivers, the method of physical punishment suffered and other questions relating to divorce and family finances.

The participants were followed over a period of 3.5 years. In that time, 257 participants had died. Of the deceased participants, only 192 had brain autopsies, which revealed that 89 of them had experienced strokes. Furthermore, forty of the participants were said to have had strokes based on medical history or an examination.

Furthermore, participants that expressed moderately high levels of emotional neglect in childhood were nearly 3 times more likely to experience a stroke than those reporting moderately low levels of emotional childhood neglect, even when other factors such as diabetes, physical activity, smoking, anxiety and heart problems were controlled.

"The results add to a growing body of evidence suggesting that early life factors such as traumatic childhood experiences influence the development of physical illness and common chronic conditions of old age" says Dr. David A. Bennett, director of the Rush Alzheimer's Disease Center and co-author of the study

Of course results may not be completely reliable since this study relies on a self-report of recalled events many years later, which may be even further clouded given the nature of the potentially traumatic memories.

Emotional Neglect in Children Linked to Increased Stroke Risk Later in Life

© www.mentalhealthblog.com

Read More

Brief Opioid Therapy May Eliminate Chronic Pain

According to team leaders, Ruth Drdla-Schutting and Jürgen Sandkühler along with their research team at the MedUni Vienna's Department of Neurophysiology (Centre for Brain Research); opioids can be used for more than temporary pain relief. Apparently, a strong enough dose can actually erase our memory traces of pain in the spinal cord.

At the most basic level, opioids bind to specific sites, called µ-opiate receptors (MOR), which suppresses the stimulation of pain. Characteristically, opioids are only known to alleviate pain while bound to these sites, therefore once treatment is ceased, pain resumes.

Typically, for chronic pain, opioids are administered continuously in moderate doses in order to achieve a permanent binding. This method may result in pain relief, however the treatment is long-term and the cause of pain cannot be eliminated.

To test their theory, that memory traces of pain can be erased with a large enough dose of opioids over a short period, “scientists recreated a surgical procedure in vivo in which pain fibres were stimulated under controlled conditions”.

"Although deep anaesthesia prevents any sensations of pain, we were able to reserve long-term synaptic potentiation in the spinal cord. Despite anaesthesia, there appears to be a memory trace for pain and a pain amplifier has engaged."

“Long-term potentiation (LTP) is a long-lasting enhancement in signal transmission between two neurons that results from stimulating them synchronously.”

Researchers administered high doses of intravenous opioids over a period of an hour and discovered that this completely removed the long-term potentiation. By doing so, this can reverse the cellular changes that cause pain memories. As such, this could actually rid the memory of the sensation that pain is amplified and longer lasting than in actuality and avoid the development chronic pain syndrome.

If proven to be an effective method of treatment, this could mean more than pain management for many people suffering with chronic pain. Current methods temporarily relieve symptoms of pain and typically require long-term opioid use. This type of treatment could greatly reduce the risk of a rapidly growing form of addiction.

Opioids Erase Memory Traces of Pain
Long-term potentiation
mu Opioid receptor

© www.mentalhealthblog.com

Read More

Drug Could Erase Bad Memories

According to researchers of the Centre for Studies on Human Stress of Louis-H. Lafontaine Hospital at the University of Montreal, our brain loses its ability to associate negative emotions with painful memories while using the drug metyrapone.

“‘Metyrapone is a drug that significantly decreases the levels of cortisol, a stress hormone that is involved in memory recall,’ explained lead author Marie-France Marin. Manipulating cortisol close to the time of forming new memories can decrease the negative emotions that may be associated with them. "The results show that when we decrease stress hormone levels at the time of recall of a negative event, we can impair the memory for this negative event with a long-lasting effect," said Dr. Sonia Lupien, who directed the research.”

Researchers taught 33 men a story that consisted of neutral and negative events. They separated the men into different groups and observed them 3 days later. A third of the participants received a single dose of metyrapone, another third received a double dose and the final third received a placebo. Researchers asked the participants to recall the story while under the influence of the drug they were given. Their memory of the story was evaluated while using the drug and again 4 days later when the drug was no longer circulating in their bloodstream.

“‘We found that the men in the group who received two doses of metyrapone were impaired when retrieving the negative events of the story, while they showed no impairment recalling the neutral parts of the story,’ Marin explained. ‘We were surprised that the decreased memory of negative information was still present once cortisol levels had returned to normal.’”

Consequently, such research could be very useful in treating mental illness. Not only could this drug be successful in treating post-traumatic stress disorder (PTSD), but it could help many people with mental health issues resulting from traumatic experiences.

Unfortunately, metyrapone is no longer commercially produced; however research on the impact of certain compounds on cortisol levels can only lead to a better understanding of the way in which our brain processes negative emotions and memories. Additionally, this type of research may lead to the discovery of other medications that are currently available or potentially more successful in erasing our bad memories.

On the other hand, use of such a drug could lead to abuse as many of us could certainly pinpoint at least one painful memory that we would be willing to let go. Also, despite those whose lives have been seriously disrupted from past trauma, it is our experiences, both positive and negative, that molds us into the person we have become. Therefore, erasing our experience of negative emotions from certain memories may be toying with our personality and possibly creating havoc in our society.

Drug May Help Overwrite Bad Memories

© www.mentalhealthblog.com

Read More

Sleep Helps Improve Memory and Creativity

It is common knowledge that sleep is an important part of healthy living, but just how important is it? We already know that sleep helps to strengthen our memories and store them in some sort of order so that they may be retrieved as needed at a later date.

Recently, the journal, Current Directions in Psychological Science, has published findings that explain how sleep is also important for the reorganization of memories. According to Jessica D. Payne of the University of Notre Dame, who co-wrote the article with Elizabeth A. Kensinger of Boston College, our brain extracts the emotional details from our memories during our slumber, while keeping the most relevant information in tact so that it may reconfigure those memories and use them to create new and creative ideas.

Payne and Kensinger study what happens to memories during sleep, and they have found that a person tends to hang on to the most emotional part of a memory. For example, if someone is shown a scene with an emotional object, such as a wrecked car, in the foreground, they're more likely to remember the emotional object than, say, the palm trees in the background -- particularly if they're tested after a night of sleep. They have also measured brain activity during sleep and found that regions of the brain involved with emotion and memory consolidation are active.

The table below displays our suggested amount of sleep that is needed at various stages in life:


So, the sleeping brain is actually quite busy. We may not realize how beneficial sleep can be for our brains. Payne says: “People who say they'll sleep when they're dead are sacrificing their ability to have good thoughts now […] we can get away with less sleep, but it has a profound effect on our cognitive abilities”.

Sweet dreams.

Sleep Makes Your Memories Stronger, and Helps With Creativity
Sleep

© www.mentalhealthblog.com

Read More

Concussions Are Quite Common In Canadian Junior Hockey

The November 2010 issue of Neurosurgical Focus illustrates concern for young players in Canadian junior ice hockey as researchers have uncovered alarming data and trends regarding head injuries and concussions.

"The aftermath of a concussion can impact memory, judgment, social conduct, reflexes, speech, balance and coordination. Epidemiological studies have suggested an association between sport concussions and both immediate and later-life cognitive impairment. As such, this is a public health issue that needs to be taken more seriously by players, parents, coaches, and medical professionals," said Dr. Echlin.

Although, the issue of sports-related head injuries has been a growing concern for some time, this new study is the first to document the significance of this concern among junior hockey players.

Specifically, the Hockey Concussion Education Project (HCEP), a cohort study conducted between 2009 and 2010, researched 67 male ice-hockey players between the ages of 16 and 21 among two fourth-tier teams.

Before the hockey season began, the players were assessed with the Sideline Concussion Assessment Test (SCAT2) and the Immediate Post-Concussion Assessment and Cognitive Test (ImPACT). Following these tests, players were monitored by one independent physician and one to three independent, non-physician observers, at each regular season game.

The disturbing results…

• 17 players experienced a total of 21 concussions in only 52 games.
  
  
• 5 of those 17 players suffered a second or recurrent concussion during the hockey season.
  
  
• 15 of the same 17 players admitted to having at least one concussion in the past, while 2 admitted to hiding the fact to continue playing.
  
  
• The positions most affected by concussion are: forward position (71%) and defense (29%).
  
  
• No concussions were incurred by goalies.
  
  
• The rate of concussion increases as the game progresses: first period (14%); second period (29%); and third period (57%).
  
  
• 24% of the concussions occurred in players directly involved in a fight.
  
  
• The mean clinical return-to-play duration in 15 players was 12.8 days.

These statistics suggest that more education is needed to convince players, coaches and parents alike that concussion really is a serious problem that should not be ignored. Testing and monitoring after a concussion occurs is extremely important, however more often than not, the extra attention required is more of a burden to most.

In addition, educating players on the dangers should reduce the number of unreported cases and the concealment of concussions to avoid sitting on the bench. Players need to be aware that concussions are quite common in sport and the tough guy act could have devastating results to both physical and mental abilities that could last decades.

Junior Ice Hockey Study Uncovers Alarming Concussion Rates

© www.mentalhealthblog.com

Read More

Estrogen Levels Affect Women's Ability To Learn

Concordia University has published new research in the popular journal, Brain and Cognition, demonstrating that high levels of estrogen, such as those found during the female ovulation period, has an affect on attention and learning.

"Although estrogen is known to play a significant role in learning and memory, there has been no clear consensus on its effect," says senior author Wayne Brake, an associate professor at Concordia's Center for Studies in Behavioural Neurobiology. "Our findings, using a well-established model of learning called latent inhibition, shows conclusively that high estrogen levels inhibit the cognitive ability in female rodents."

Findings in this study resulted from experiments on the latent inhibition of rats. Latent inhibition is a term derived from Classical conditioning. It occurs when a subject takes longer to give meaning to a stimulus that had no previous significance than it would when associated with a new stimulus. It is a natural tendency to disregard or inhibit forming a memory by preventing associative learning of a stimulus with no associated consequence. It is an unconscious response and presumed to prevent sensory overload. “Latent inhibition is observed in many species, and is believed to be an integral part of learning, enabling an organism to interact successfully in an environment.”

The research team discovered that estrogen has a direct effect on the brain. In their experiment, rats were repeatedly exposed to a specific tone that had no consequence linked to it. After some exposure rats began ignoring the tone because they were used to it. The researchers then linked the tone with a different stimulus. Results showed that rats with higher levels of estrogen took much longer to form the association than rats with low levels of estrogen.

"We only observed this effect in adult female rats," says Brake. "This and our other findings indicate that estrogen directly effects the brain, perhaps by interfering with brain signaling molecules. Our study helps clear up the controversy about the effects of estrogen, the next step is to look at how this occurs."

Can't Focus? Maybe It's the Wrong Time of Month, Finds Estrogen Study on Attention and Learning
Latent inhibition

© www.mentalhealthblog.com

Read More

It's Not a Concussion; It's a Brain Injury

The term concussion originates from the Latin concutera, which means to shake violently or the Latin concussus, which refers to the action of striking together. It is the most common type of traumatic brain injury. The terms mild brain injury, mild traumatic brain injury (MTBI), mild head injury (MHI), and minor head trauma and concussion are often used interchangeably.


The American Academy of Neurology Guidelines ranks the severity of a concussion into 3 grades:

Grade I - Confusion, symptoms last < 15 minutes, no loss of consciousness

Grade II - Symptoms last > 15 minutes, no loss of consciousness

Grade III - Loss of consciousness

Concussion Symptoms:

• Headache
  
• Dizziness
  
• Vomiting
  
• Nausea
  
• Lack of motor coordination
  
• Difficulty balancing
  
• Light sensitivity
  
• Seeing bright lights
  
• Blurred vision
  
• Double vision
  
• Tinnitus
  
• Convulsions
  
• Confusion
  
• Disorientation
  
• Difficulty focusing attention
  
• Loss of consciousness
  
• Post-traumatic amnesia
  
• Confusion
  
• Slurred or incoherent speech
  
• Changes in sleeping patterns
  
• Difficulty with reasoning, concentrating, and performing everyday activities
  
• Crankiness
  
• Loss of interest in favorite activities or items
  
• Tearfulness
  
• Displays of emotion that are inappropriate to the situation

**Common symptoms in children include restlessness, lethargy, and irritability.

Typically symptoms will go away without treatment. Roughly 1% of treated concussions require surgery for a brain injury. Most often plenty of rest is prescribed with a gradual return to normal activities at a pace that does not cause symptoms to worsen.

Medications may be prescribed to treat symptoms associated with the concussion, such as sleep problems and depression. Analgesics such as ibuprofen can be taken for headaches that frequently occur after a concussion, but acetaminophen is preferred to minimize the risk for complications, such as intracranial hemorrhage. Individuals are advised not to drink alcohol or take drugs that have not been approved by a doctor as they may interfere with the healing process.

Observation to monitor for worsening condition is an important part of treatment. Unconsciousness or altered mental status, convulsions, severe, persistent headache, extremity weakness, vomiting, or new bleeding or deafness in either or both ears suggests that another visit to the doctor is needed. No conclusive evidence suggests that it is necessary to wake a patient up every few hours or not.

Symptoms usually go away entirely within three weeks, though they may persist, or complications may occur. Although the mortality rate is almost zero, repeated concussions can cause cumulative brain damage such as dementia pugilistica or severe complications such as second-impact syndrome.

Certain factors may lengthen recovery time, such as longer periods of amnesia or loss of consciousness, substance abuse, clinical depression, poor health or additional injuries sustained and life stress. For unknown reasons, having had one concussion significantly increases a person's risk of having another. Having previously sustained a concussion has been found to be a strong factor increasing the likelihood of a concussion in the future. The prognosis is likely to differ between adults and children; however little research has been done on concussion in the pediatric population. Concern exists that severe concussions could interfere with brain development in children.

A 2009 study published in Brain found that individuals with a history of concussions might demonstrate a decline in both physical and mental performance for longer than 30 years. Compared to their peers with no history of brain trauma, victims of concussion exhibited the following effects:

• A decrease in episodic memory (times, places, associated emotions, and other contextual knowledge)
• A decrease in response inhibition
• Delayed P3a/P3b waves recorded via EEG
• An increase in the cortical silence period
• Reduced muscle speed otherwise known as bradykinesia (slow movement)

In recent news, Canadian researchers suggest that the term concussion is scraped from medical terminology as doctors and parents quite often underestimate the severity of these types of injuries.

“Carol DeMatteo, an occupational therapist and associate clinical professor in the School of Rehabilitation Science at McMaster University in Hamilton, Ont., says children diagnosed with concussions are treated differently from kids with other mild brain injuries.” These children are often sent home from the hospital and returned to school much sooner than those treated for mild brain injuries.

The term mild brain injury takes on a more negative connotation that concussion, which tends to suggests that the prognosis is obviously good. Concussion should not be taken as lightly as evidence suggests people who have experience multiple concussions risk neurological damage or even Alzheimer's disease and other dementias.

Natasha Richardson’s tragic death is a perfect example of what might happen when brain injuries are not taken seriously enough. On 16 March 2009, Richardson sustained a head injury when she fell while taking a skiing lesson at the Mont Tremblant Resort in Quebec. The injury was followed by a lucid interval, when she appeared to be fine as she was able to talk and act normally. Paramedics were told they were not needed. She returned to her hotel room and about three hours later was taken to a local hospital in Sainte-Agathe-des-Monts after complaining of a headache. About 7 hours following her fall, she was transferred by ambulance to Hôpital du Sacré-Cœur, in Montreal, in critical condition. The following day she was flown to Lenox Hill Hospital in New York City, where she died on 18 March. An autopsy conducted by the New York City Medical Examiners Office on 19 March revealed the cause of death was an "epidural hematoma due to blunt impact to the head", and her death was ruled an accident. There is a lot of controversy surrounding her death as many believe it could have been prevented with proper medical care.

If the term "mild traumatic brain injury" replaced "concussion", it would help people understand that this type of injury is serious and that it is an injury to the brain, not just the head. It could also save lives and prevent more serious complications later in life.

'Concussion' underplays severity of injury: doctors
Concussion
Natasha Richardson

© www.mentalhealthblog.com

Read More

No Evidence That Ginkgo Biloba Benefits Cognition

A recent study, Ginkgo Evaluation of Memory (GEM), by Beth E. Snitz, Ph.D., of the University of Pittsburgh, demonstrates that the use of the herbal supplement Ginkgo biloba does not slow the rate of cognitive decline among older adults as construed.

“The randomized, double-blind, placebo-controlled clinical trial included 3,069 community-dwelling participants, ages 72 to 96 years, who received a twice-daily dose of 120-mg extract of G biloba (n = 1,545) or identical-appearing placebo (n = 1,524). The study was conducted at six academic medical centers in the United States between 2000 and 2008, with a median (midpoint) follow-up of 6.1 years. Change in cognition was assessed by various tests and measures.”

In 2000, older adults that had normal to mild cognitive impairment were chosen and observed. The researchers placed the subjects into 3 distinct groups. Some were given a placebo over the 8 year period. Others were given either Ginkgo biloba or the placebo, where their group identity was not disclosed to the participant or the experimenter. The third group was randomly assigned to either of the groups. Double-blind studies are said to achieve greater scientific rigor than other types of research. The conclusion of this double-blind study is that Ginkgo biloba is not effective in reducing the incidence of Alzheimer dementia or dementia in general. In addition, no evidence was found to support any effects on memory, language, attention, visuospatial abilities and executive functions. Furthermore, no differences were detected through age, sex, race, education or baseline cognitive status.

Basically, no evidence was found to support the widely marketed fact that Ginkgo biloba slows the rate of cognitive decline.

What is Ginkgo Biloba?

Ginkgos are very large trees, normally reaching a height of 66–115 feet, with some specimens in China being over 50 m. The tree has an angular crown and long, somewhat erratic branches, and is usually deep rooted and resistant to wind and snow damage. A combination of resistance to disease, insect-resistant wood and the ability to form aerial roots and sprouts makes ginkgos long-lived, with some specimens claimed to be more than 2,500 years old. Extreme examples of the Ginkgo's tenacity may be seen in Hiroshima, Japan, where six trees growing between 1–2 km from the 1945 atom bomb explosion were among the few living things in the area to survive the blast. While almost all other plants and animals in the area were destroyed, the ginkgos, though charred, survived and were soon healthy again. The trees are alive to this day.

Extracts of Ginkgo leaves contain flavonoid glycosides and terpenoids and have been used pharmaceutically. Ginkgo supplements are usually taken in the range of 40–200 mg per day. Ginkgo has many alleged nootropic properties, and is mainly used as a memory and concentration enhancer, and an anti-vertigo agent. According to some studies, in a few cases, Ginkgo can significantly improve attention in healthy individuals. Allegedly, the effect is almost immediate and reaches its peak in 2.5 hours after intake.

Ginkgo has been used for…

• Alzheimer's disease
  
• Improving blood flow
  
• Protecting against oxidative cell damage
  
• Blocking the effects of platelet-activating factor (platelet aggregation, blood clotting)
  
• Intermittent claudication
  
• Easing the symptoms of tinnitus
  
• Improving cognition and fatigue in those with multiple sclerosis
  
• Arresting the development of vitiligo

Ginkgo may have undesirable effects, especially for individuals with blood circulation disorders and those taking anticoagulants such as ibuprofen, aspirin, or warfarin. Ginkgo should also not be used by people who are taking certain types of antidepressants (monoamine oxidase inhibitors and selective serotonin reuptake inhibitors) or by pregnant women, without first consulting a doctor.

Side effects can include…

• possible increased risk of bleeding
  
• gastrointestinal discomfort
  
• nausea
  
• vomiting
  
• diarrhea
  
• headaches
  
• dizziness
  
• heart palpitations
  
• restlessness

Other precautions…

Ginkgo biloba leaves contain long-chain alkylphenols together with the extremely potent allergens, the urushiols (similar to poison ivy). Individuals with a history of strong allergic reactions to poison ivy, mangoes, and other urushiol-producing plants are more likely to experience an adverse reaction when consuming Ginkgo-containing pills, combinations, or extracts.

The nut-like gametophytes inside the seeds are particularly esteemed in Asia, and are a traditional Chinese food. When eaten by children, in large quantities (over 5 seeds a day), or over a long period, the raw gametophyte (meat) of the seed can cause poisoning by MPN (4-methoxypyridoxine).

Bottom line...

It is very important to remember that herbal supplements are not regulated by the FDA in the US and Canada’s regulation of such health products is quite often confusing and inconsistent. Therefore, personal responsibility is essential when relying on this type of treatment.

Ginkgo Biloba Does Not Appear to Slow Rate of Cognitive Decline

Wikipedia

© www.mentalhealthblog.com

Read More

The Brain Can Distinguish Religion From Fact

Lead author, Sam Harris, professor of psychiatry at the UCLA Staglin Center for Cognitive Neuroscience, and co-lead author, Jonas Kaplan, research assistant professor at the USC's Brain and Creativity Institute, performed the first neuroimaging study to systematically compare religious faith with ordinary cognition.

The study has demonstrated that our brains respond differently to religious and nonreligious statements, however the information seems to get processed in the same brain regions. In other words, our judgement on the truthfulness of religious statements occurs within the same brain regions, despite whether we believe or not.

The study included 30 adult subjects, in which half were devout Christians and the remaining half were non-believers. All subjects judged the reliability of religious and non-religious statements while undergoing three functional MRI (fMRI) scans. The statements used were certain to generate agreement in both groups.

The ventromedial prefrontal cortex (VMPFC), a brain region said to be involved with reward and judgements of self-relevance, showed increased activity when evaluating statements related to beliefs in God, the Virgin Birth and ordinary facts.

However, religious thought appears to be more associated with areas of the ventromedial prefrontal cortex that govern emotion, self-representation and cognitive conflict in both believers and nonbelievers.

Conversely, our thoughts about ordinary facts seem more reliant upon areas associated with memory retrieval. This study helps to illustrate that no matter how much or how often religion is forced upon us, our brains still believe that religion is not based on factual knowledge.

Interestingly, “activity in the brain's anterior cingulate cortex, an area associated with cognitive conflict and uncertainty, suggested that both believers and nonbelievers experienced greater uncertainty when evaluating religious statements.”

This research suggests that one day it may be possible to distinguish religious belief versus disbelief via neuroimaging techniques. “These results may have many areas of application — ranging from the neuropsychology of religion, to the use of 'belief-detection' as a surrogate for 'lie-detection,' to understanding how the practice of science itself, and truth-claims generally, emerge from the biology of the human brain." In addition, this type of research could shed new light on the study of cult behaviours.

Where Religious Belief And Disbelief Meet

© www.mentalhealthblog.com

Read More

Walnuts Improve Age-Related Motor and Cognitive Shortfalls

Walnuts are said to be rich in fiber, vitamin B, magnesium, and antioxidants such as Vitamin E. They are also loaded with more omega 3 fatty acids than any other types of nuts. Omega 3 fatty acid has been shown to lower cholesterol. In addition, walnuts assist in reducing the risk of heart disease by improving elasticity of blood vessels and reducing plaque accumulation.

Furthermore, the Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University in Boston, Massachusetts has conducted a study observing
the effects of walnut consumption on behavioural and motor skills.

Our brain ages with us and as such, changes occur that alter or impair neurons in our brain. The synaptic connections in the brain can become weak or change entirely altering the functions of relative connections. Increased oxidative damage to neural tissue also alters the way in which our brain functions. In the study, aged rodents displayed these types of changes behaviorally through impairments in performance on age-related tasks such as balance, coordination, and spatial working memory.

The study consisted of 4 distinct groups of aged rats of similar weight. The diet of the first group of rats consisted of a chow mix containing 2% walnuts, the second 6%, third 9% and fourth 0%. The rats were then subjected to a battery of memory and motor tests. In comparison, the group that ingested 6% walnut in their chow mix would be equivalent to a human eating 1 ounce or 7 to 9 walnuts per day.

“The study found that in aged rats, the diets containing 2 percent or 6 percent walnuts were able to improve age-related motor and cognitive shortfalls, while the 9 percent walnut diet impaired reference memory.”

It seems that a healthy diet and 7 to 9 walnuts per day could be beneficial in reducing the effects of aging on motor and behaviour skills.

Health Benefits of Walnuts
Adding Walnuts To Good Diet May Help Older People Improve Motor And Behavioral Skills

© www.mentalhealthblog.com

Read More